Elisabeth Fox, MD
Otolaryngology · Keene, NHNPI 1053491704
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Optinose US, Inc. at 29.0% of the total. Reporting peaked in 2023 at $358 and has fallen 87.9% since, to $43 in 2024.
Across 46 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$302
- Sanofi$119
- Kowa Pharmaceuticals America, Inc.$112
- Medtronic$105
- GSK$93
- Regeneron Healthcare Solutions, Inc.$63
- plus $248 from 7 others
What the payments were for
- Food & beverage$1,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 16 | $302 |
| Sanofi | 3 | $119 |
| Kowa Pharmaceuticals America, Inc. | 7 | $112 |
| Medtronic | 1 | $105 |
| GSK | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Smith+Nephew | 2 | $58 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Stryker | 2 | $48 |
| Acclarent, Inc | 2 | $30 |
| Aerin Medical Inc. | 1 | $29 |
| Merck | 1 | $19 |
| Checkpoint Surgical, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$105
How this compares
$1,041 in reported general payments places this provider in the 70th percentile of 44 otolaryngology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 28 | $821 |
| Omeprazole | 43 | $677 |
| Cefdinir | 18 | $443 |
| Pantoprazole Sodium | 38 | $281 |
| Methylprednisolone | 16 | $155 |
| Ofloxacin | 11 | $125 |
| Famotidine | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Keene
- Avery NelsonKeene$2K
- Angela DamianoKeene$2K
- Paul RighiKeene$0
- James BartelsManchester$5K
- Joseph PaydarfarLebanon$5K
- Michael ToscanoDover$4K
- Taraneh AzarPortsmouth$4K
- Christopher KnoxRochester$3K
- Keith JorgensenDerry$2K
- Ross JohnstonLebanon$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.